NovoCure Limited Increase (Decrease) in Other Noncurrent Assets
NovoCure Limited (NVCR) reported Increase (Decrease) in Other Noncurrent Assets of -$2.91 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-07-23
- NovoCure Limited increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$2.91M.
- NovoCure Limited increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$2.04M.
- NovoCure Limited increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$4.37M, a 860.80% decline year-over-year.
- NovoCure Limited increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$2.49M.
- NovoCure Limited increase (decrease) in other noncurrent assets for fiscal 2024 was -$7.39M.
- NovoCure Limited increase (decrease) in other noncurrent assets for fiscal 2023 was -$4.07M.
- NovoCure Limited increase (decrease) in other noncurrent assets for fiscal 2022 was -$7.11M.
- NovoCure Limited increase (decrease) in other noncurrent assets for fiscal 2021 was -$4.52M, a 430.82% decline from fiscal 2020.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 3 month as first filed | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 6 month as first filed | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.91M 10-Q · filed 2026-07-23 | -$4.95M 10-Q · filed 2026-07-23 | -$9.32M derived: sum of 3 quarters · filed 2026-07-23 | -$11.81M derived: sum of 4 quarters · filed 2026-07-23 | ||
| 2026-03-31 | -$2.04M 10-Q · filed 2026-04-30 | -$6.41M derived: sum of 2 quarters · filed 2026-07-23 | -$8.90M derived: sum of 3 quarters · filed 2026-07-23 | -$10.31M derived: sum of 4 quarters · filed 2026-07-23 | ||
| 2025-12-31 | -$4.37M derived: 10-Q 12 month − 10-Q 9 month · filed 2026-07-23 | -$6.86M derived: sum of 2 quarters · filed 2026-07-23 | -$8.27M derived: sum of 3 quarters · filed 2026-07-23 | -$10.85M 10-Q · filed 2026-07-23 | ||
| 2025-09-30 | -$2.49M 10-Q · filed 2025-10-30 | -$3.90M derived: sum of 2 quarters · filed 2026-07-23 | -$6.48M 10-Q · filed 2025-10-30 | -$5.91M derived: sum of 4 quarters · filed 2026-07-23 | ||
| 2025-06-30 | -$1.41M 10-Q · filed 2026-07-23 | -$3.99M 10-Q · filed 2026-07-23 | -$3.42M derived: sum of 3 quarters · filed 2026-07-23 | -$5.32M derived: sum of 4 quarters · filed 2026-07-23 | ||
| 2025-03-31 | -$2.58M 10-Q · filed 2026-04-30 | -$2.00M derived: sum of 2 quarters · filed 2026-04-30 | -$3.91M derived: sum of 3 quarters · filed 2026-04-30 | -$8.80M derived: sum of 4 quarters · filed 2026-04-30 | ||
| 2024-12-31 | $574.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.33M derived: sum of 2 quarters · filed 2026-02-26 | -$6.22M derived: sum of 3 quarters · filed 2026-02-26 | -$7.39M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | -$1.91M 10-Q · filed 2025-10-30 | -$6.79M derived: sum of 2 quarters · filed 2025-10-30 | -$7.97M 10-Q · filed 2025-10-30 | -$8.46M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | -$4.89M 10-Q · filed 2025-07-24 | -$6.06M 10-Q · filed 2025-07-24 | -$6.55M derived: sum of 3 quarters · filed 2026-02-26 | -$10.52M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | -$1.17M 10-Q · filed 2025-04-24 | -$1.66M derived: sum of 2 quarters · filed 2026-02-26 | -$5.63M derived: sum of 3 quarters · filed 2026-02-26 | -$3.71M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | -$487.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$4.46M derived: sum of 2 quarters · filed 2026-02-26 | -$2.54M derived: sum of 3 quarters · filed 2026-02-26 | -$4.07M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | -$3.97M 10-Q · filed 2024-10-30 | -$2.05M derived: sum of 2 quarters · filed 2024-10-30 | -$3.58M 10-Q · filed 2024-10-30 | -$4.81M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $1.92M 10-Q · filed 2024-07-25 | $386.00K 10-Q · filed 2024-07-25 | -$836.00K derived: sum of 3 quarters · filed 2025-02-27 | -$2.50M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | -$1.53M 10-Q · filed 2024-05-02 | -$2.76M derived: sum of 2 quarters · filed 2025-02-27 | -$4.42M derived: sum of 3 quarters · filed 2025-02-27 | -$6.78M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$2.89M derived: sum of 2 quarters · filed 2025-02-27 | -$5.24M derived: sum of 3 quarters · filed 2025-02-27 | -$7.11M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | -$1.67M 10-Q · filed 2023-10-26 | -$4.02M derived: sum of 2 quarters · filed 2023-10-26 | -$5.88M 10-Q · filed 2023-10-26 | -$6.02M derived: sum of 4 quarters · filed 2024-02-22 | ||
| 2022-06-30 | -$2.36M 10-Q · filed 2023-07-27 | -$4.22M 10-Q · filed 2023-07-27 | -$4.36M derived: sum of 3 quarters · filed 2024-02-22 | -$5.72M derived: sum of 4 quarters · filed 2024-02-22 | ||
| 2022-03-31 | -$1.86M 10-Q · filed 2023-05-04 | -$2.00M derived: sum of 2 quarters · filed 2024-02-22 | -$3.37M derived: sum of 3 quarters · filed 2024-02-22 | -$4.95M derived: sum of 4 quarters · filed 2024-02-22 | ||
| 2021-12-31 | -$136.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$1.50M derived: sum of 2 quarters · filed 2024-02-22 | -$3.09M derived: sum of 3 quarters · filed 2024-02-22 | -$4.52M 10-K · filed 2024-02-22 | ||
| 2021-09-30 | -$1.37M 10-Q · filed 2022-10-27 | -$2.95M derived: sum of 2 quarters · filed 2022-10-27 | -$4.38M 10-Q · filed 2022-10-27 | -$5.81M derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-06-30 | -$1.58M 10-Q · filed 2022-07-28 | -$3.02M 10-Q · filed 2022-07-28 | -$4.44M derived: sum of 3 quarters · filed 2023-02-23 | $729.00K derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-03-31 | -$1.43M 10-Q · filed 2022-04-28 | -$2.86M derived: sum of 2 quarters · filed 2023-02-23 | $2.31M derived: sum of 3 quarters · filed 2023-02-23 | $1.17M derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2020-12-31 | -$1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $3.75M derived: sum of 2 quarters · filed 2023-02-23 | $2.60M derived: sum of 3 quarters · filed 2023-02-23 | $1.37M 10-K · filed 2023-02-23 | ||
| 2020-09-30 | $5.17M 10-Q · filed 2021-10-28 | $4.03M derived: sum of 2 quarters · filed 2021-10-28 | $2.79M 10-Q · filed 2021-10-28 | $500.00K derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-06-30 | -$1.14M 10-Q · filed 2021-07-29 | -$2.38M 10-Q · filed 2021-07-29 | -$4.67M derived: sum of 3 quarters · filed 2022-02-24 | -$5.74M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-03-31 | -$1.24M 10-Q · filed 2021-04-29 | -$3.53M derived: sum of 2 quarters · filed 2022-02-24 | -$4.60M derived: sum of 3 quarters · filed 2022-02-24 | -$4.77M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2019-12-31 | -$2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$3.36M derived: sum of 2 quarters · filed 2022-02-24 | -$3.53M derived: sum of 3 quarters · filed 2022-02-24 | -$3.45M 10-K · filed 2022-02-24 | ||
| 2019-09-30 | -$1.07M 10-Q · filed 2020-10-29 | -$1.24M derived: sum of 2 quarters · filed 2020-10-29 | -$1.15M 10-Q · filed 2020-10-29 | -$945.00K derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-06-30 | -$168.00K 10-Q/A · filed 2020-10-02 | $632.00K 10-Q · filed 2019-07-25 | -$82.00K 10-Q/A · filed 2020-10-02 | $2.53M 10-Q · filed 2019-07-25 | $124.00K derived: sum of 3 quarters · filed 2021-02-25 | -$31.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $86.00K 10-Q/A · filed 2020-10-02 | $1.90M 10-Q · filed 2019-05-02 | $292.00K derived: sum of 2 quarters · filed 2021-02-25 | $137.00K derived: sum of 3 quarters · filed 2021-02-25 | $415.00K derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | $206.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $51.00K derived: sum of 2 quarters · filed 2021-02-25 | $329.00K derived: sum of 3 quarters · filed 2021-02-25 | $949.00K 10-K · filed 2021-02-25 | ||
| 2018-09-30 | -$155.00K 10-Q · filed 2019-10-31 | $123.00K derived: sum of 2 quarters · filed 2019-10-31 | $743.00K 10-Q · filed 2019-10-31 | $765.00K derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-06-30 | $278.00K 10-Q · filed 2019-07-25 | $898.00K 10-Q · filed 2019-07-25 | $920.00K derived: sum of 3 quarters · filed 2020-02-27 | $1.16M derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-03-31 | $620.00K 10-Q · filed 2019-05-02 | $642.00K derived: sum of 2 quarters · filed 2020-02-27 | $880.00K derived: sum of 3 quarters · filed 2020-02-27 | $918.00K derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2017-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $260.00K derived: sum of 2 quarters · filed 2020-02-27 | $298.00K derived: sum of 3 quarters · filed 2020-02-27 | $554.00K 10-K · filed 2020-02-27 | ||
| 2017-09-30 | $238.00K 10-Q · filed 2018-10-25 | $276.00K derived: sum of 2 quarters · filed 2018-10-25 | $532.00K 10-Q · filed 2018-10-25 | $420.00K derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2017-06-30 | $38.00K 10-Q · filed 2018-07-26 | $294.00K 10-Q · filed 2018-07-26 | $182.00K derived: sum of 3 quarters · filed 2019-02-28 | $708.00K derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2017-03-31 | $256.00K 10-Q · filed 2018-04-26 | $144.00K derived: sum of 2 quarters · filed 2019-02-28 | $670.00K derived: sum of 3 quarters · filed 2019-02-28 | $781.00K derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2016-12-31 | -$112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $414.00K derived: sum of 2 quarters · filed 2019-02-28 | $525.00K derived: sum of 3 quarters · filed 2019-02-28 | $692.00K 10-K · filed 2019-02-28 | ||
| 2016-09-30 | $526.00K 10-Q · filed 2017-10-26 | $637.00K derived: sum of 2 quarters · filed 2017-10-26 | $804.00K 10-Q · filed 2017-10-26 | $1.26M derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2016-06-30 | $111.00K 10-Q · filed 2017-07-27 | $278.00K 10-Q · filed 2017-07-27 | $738.00K derived: sum of 3 quarters · filed 2018-02-22 | $488.00K derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2016-03-31 | $167.00K 10-Q · filed 2017-04-27 | $627.00K derived: sum of 2 quarters · filed 2018-02-22 | $377.00K derived: sum of 3 quarters · filed 2018-02-22 | $538.00K derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2015-12-31 | $460.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $210.00K derived: sum of 2 quarters · filed 2018-02-22 | $371.00K derived: sum of 3 quarters · filed 2018-02-22 | $381.00K 10-K · filed 2018-02-22 | ||
| 2015-09-30 | -$250.00K 10-Q · filed 2016-11-02 | -$89.00K derived: sum of 2 quarters · filed 2016-11-02 | -$79.00K 10-Q · filed 2016-11-02 | -$15.00K derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-06-30 | $161.00K 10-Q · filed 2016-07-28 | $171.00K 10-Q · filed 2016-07-28 | $235.00K derived: sum of 3 quarters · filed 2017-02-23 | |||
| 2015-03-31 | $10.00K 10-Q · filed 2016-05-10 | $74.00K derived: sum of 2 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | $64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $44.00K 10-K · filed 2017-02-23 | ||||
| 2014-09-30 | -$20.00K 10-Q · filed 2015-10-27 | |||||
| 2013-12-31 | $44.00K 10-K · filed 2016-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |